363.65
price up icon1.13%   4.07
after-market After Hours: 363.65
loading
United Therapeutics Corp stock is traded at $363.65, with a volume of 208.68K. It is up +1.13% in the last 24 hours and down -2.48% over the past month. United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.
See More
Previous Close:
$359.58
Open:
$359.59
24h Volume:
208.68K
Relative Volume:
0.64
Market Cap:
$16.23B
Revenue:
$2.76B
Net Income/Loss:
$1.11B
P/E Ratio:
20.04
EPS:
18.15
Net Cash Flow:
$898.10M
1W Performance:
-2.46%
1M Performance:
-2.48%
6M Performance:
+15.06%
1Y Performance:
+66.10%
1-Day Range:
Value
$356.00
$364.95
1-Week Range:
Value
$350.60
$383.00
52-Week Range:
Value
$208.62
$417.81

United Therapeutics Corp Stock (UTHR) Company Profile

Name
Name
United Therapeutics Corp
Name
Phone
(301) 608-9292
Name
Address
1000 SPRING ST, SILVER SPRING, MD
Name
Employee
1,168
Name
Twitter
Name
Next Earnings Date
2024-10-30
Name
Latest SEC Filings
Name
UTHR's Discussions on Twitter

Compare UTHR with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
UTHR
United Therapeutics Corp
363.65 16.23B 2.76B 1.11B 898.10M 22.77
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
405.27 104.37B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
715.13 78.59B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
628.32 37.57B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
242.26 31.25B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
113.51 27.21B 3.30B -501.07M 1.03B -2.1146

United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-11-24 Downgrade Morgan Stanley Overweight → Equal-Weight
Feb-12-24 Upgrade Goldman Sell → Neutral
Feb-05-24 Initiated Leerink Partners Outperform
Dec-08-23 Initiated Wells Fargo Overweight
Dec-06-22 Initiated UBS Buy
Dec-05-22 Initiated Goldman Sell
Oct-11-22 Initiated Morgan Stanley Overweight
Sep-20-22 Reiterated BofA Securities Underperform
Sep-19-22 Resumed Wedbush Outperform
Feb-11-22 Initiated BTIG Research Neutral
Jul-14-21 Upgrade Argus Hold → Buy
Apr-26-21 Resumed Credit Suisse Outperform
Feb-01-21 Upgrade H.C. Wainwright Neutral → Buy
Sep-14-20 Resumed JP Morgan Overweight
Jun-25-20 Reiterated H.C. Wainwright Neutral
Mar-10-20 Upgrade Jefferies Hold → Buy
Feb-27-20 Upgrade Cowen Market Perform → Outperform
Jan-31-20 Upgrade JP Morgan Neutral → Overweight
Dec-03-19 Initiated BofA/Merrill Underperform
Aug-01-19 Upgrade Jefferies Underperform → Hold
Aug-01-19 Upgrade Ladenburg Thalmann Neutral → Buy
Jul-01-19 Upgrade Credit Suisse Neutral → Outperform
May-17-19 Upgrade UBS Sell → Neutral
May-09-19 Upgrade Credit Suisse Underperform → Neutral
Oct-12-18 Upgrade Standpoint Research Hold → Buy
Aug-08-18 Downgrade Credit Suisse Neutral → Underperform
Apr-03-18 Upgrade Credit Suisse Underperform → Neutral
Feb-22-18 Reiterated Barclays Underweight
Jan-18-18 Resumed Credit Suisse Underperform
Dec-27-17 Reiterated Wedbush Outperform
Apr-27-17 Reiterated Wedbush Outperform
Mar-30-17 Initiated UBS Sell
Mar-16-17 Initiated Credit Suisse Underperform
View All

United Therapeutics Corp Stock (UTHR) Latest News

pulisher
09:40 AM

Why United Therapeutics (UTHR) is a Top Value Stock for the Long-Term - Yahoo Finance

09:40 AM
pulisher
08:42 AM

Here are Updates on United Therapeutics Corp. (UTHR) - Insider Monkey

08:42 AM
pulisher
Dec 19, 2024

Insider Sell: Louis Sullivan Sells 26,209 Shares of United Thera - GuruFocus.com

Dec 19, 2024
pulisher
Dec 19, 2024

United Therapeutics Co. (NASDAQ:UTHR) Director Sells $9,781,722.98 in Stock - MarketBeat

Dec 19, 2024
pulisher
Dec 19, 2024

United Therapeutics director sells shares worth $9.78 million - Investing.com

Dec 19, 2024
pulisher
Dec 18, 2024

United Therapeutics president and COO sells $3.7 million in stock - Investing.com India

Dec 18, 2024
pulisher
Dec 18, 2024

United Therapeutics (NASDAQ:UTHR) Trading Down 4.4%Here's Why - MarketBeat

Dec 18, 2024
pulisher
Dec 18, 2024

United Therapeutics 'no longer pursuing' nearly 350 acres in Hackett Hill area - The Union Leader

Dec 18, 2024
pulisher
Dec 17, 2024

United Therapeutics president and COO sells $3.7 million in stock By Investing.com - Investing.com Australia

Dec 17, 2024
pulisher
Dec 17, 2024

United Therapeutics Makes History: First-Ever Genetically Modified Pig Kidney Transplant Success - StockTitan

Dec 17, 2024
pulisher
Dec 16, 2024

United Therapeutics cancels plans to buy Hackett Hill property from Manchester - New Hampshire Business Review

Dec 16, 2024
pulisher
Dec 16, 2024

Franklin Resources Inc. Grows Stake in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Dec 16, 2024
pulisher
Dec 15, 2024

Tidal Investments LLC Acquires 2,803 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Dec 15, 2024
pulisher
Dec 15, 2024

Lord Abbett & CO. LLC Buys 46,170 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Dec 15, 2024
pulisher
Dec 14, 2024

Oddo BHF Asset Management Sas Makes New Investment in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Dec 14, 2024
pulisher
Dec 14, 2024

Geode Capital Management LLC Purchases 45,566 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Dec 14, 2024
pulisher
Dec 13, 2024

Tri Ri Asset Management Corp Makes New Investment in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Dec 13, 2024
pulisher
Dec 11, 2024

iA Global Asset Management Inc. Lowers Stock Position in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Dec 11, 2024
pulisher
Dec 11, 2024

United Therapeutics president sells $3.45 million in stock By Investing.com - Investing.com Canada

Dec 11, 2024
pulisher
Dec 10, 2024

United Therapeutics president sells $3.45 million in stock - Investing.com

Dec 10, 2024
pulisher
Dec 10, 2024

Brophy Wealth Management LLC Invests $809,000 in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Dec 10, 2024
pulisher
Dec 10, 2024

With EPS Growth And More, United Therapeutics (NASDAQ:UTHR) Makes An Interesting Case - Simply Wall St

Dec 10, 2024
pulisher
Dec 09, 2024

United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Worldquant Millennium Advisors LLC - MarketBeat

Dec 09, 2024
pulisher
Dec 08, 2024

State Street Corp Decreases Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Dec 08, 2024
pulisher
Dec 08, 2024

Dorsey Wright & Associates Purchases New Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Dec 08, 2024
pulisher
Dec 07, 2024

United Therapeutics Co. (NASDAQ:UTHR) EVP Sells $2,882,649.00 in Stock - MarketBeat

Dec 07, 2024
pulisher
Dec 07, 2024

United Therapeutics' EVP sells $2.88 million in stock - Investing.com India

Dec 07, 2024
pulisher
Dec 06, 2024

United Therapeutics' EVP sells $2.88 million in stock By Investing.com - Investing.com Canada

Dec 06, 2024
pulisher
Dec 06, 2024

United Therapeutics Co. (NASDAQ:UTHR) Shares Acquired by Chevy Chase Trust Holdings LLC - MarketBeat

Dec 06, 2024
pulisher
Dec 05, 2024

Janus Henderson Group PLC Acquires 50,409 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Dec 05, 2024
pulisher
Dec 05, 2024

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Sells 1,531 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Dec 05, 2024
pulisher
Dec 05, 2024

United Therapeutics Co. (NASDAQ:UTHR) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Dec 05, 2024
pulisher
Dec 04, 2024

United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Parkman Healthcare Partners LLC - MarketBeat

Dec 04, 2024
pulisher
Dec 04, 2024

PDT Partners LLC Reduces Stake in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Dec 04, 2024
pulisher
Dec 04, 2024

Edgestream Partners L.P. Buys New Position in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Dec 04, 2024
pulisher
Dec 03, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $76.21 Million Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Dec 03, 2024
pulisher
Dec 02, 2024

PH-ILD Pipeline 2024: Clinical Trials Assessment, FDA - openPR

Dec 02, 2024
pulisher
Dec 02, 2024

45,266 Shares in United Therapeutics Co. (NASDAQ:UTHR) Acquired by Erste Asset Management GmbH - MarketBeat

Dec 02, 2024
pulisher
Dec 02, 2024

Zurcher Kantonalbank Zurich Cantonalbank Has $10.44 Million Position in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Dec 02, 2024
pulisher
Dec 02, 2024

BNP Paribas Financial Markets Has $12.25 Million Stock Position in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Dec 02, 2024
pulisher
Dec 01, 2024

True Wealth Design LLC Sells 3,274 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Dec 01, 2024
pulisher
Dec 01, 2024

Cerity Partners LLC Acquires 4,005 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Dec 01, 2024
pulisher
Dec 01, 2024

Fmr LLC Acquires 314,004 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Dec 01, 2024
pulisher
Dec 01, 2024

United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Bank of Montreal Can - MarketBeat

Dec 01, 2024
pulisher
Nov 30, 2024

United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Martingale Asset Management L P - MarketBeat

Nov 30, 2024
pulisher
Nov 29, 2024

United Therapeutics Co. (NASDAQ:UTHR) Holdings Trimmed by Crawford Fund Management LLC - MarketBeat

Nov 29, 2024
pulisher
Nov 28, 2024

The 3.8% return this week takes United Therapeutics' (NASDAQ:UTHR) shareholders five-year gains to 314% - Yahoo Finance

Nov 28, 2024
pulisher
Nov 28, 2024

United Therapeutics Co. (NASDAQ:UTHR) Shares Bought by Bridgewater Associates LP - MarketBeat

Nov 28, 2024
pulisher
Nov 28, 2024

Glenmede Trust Co. NA Boosts Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Nov 28, 2024
pulisher
Nov 27, 2024

United Therapeutics president sells shares worth $3.73 million By Investing.com - Investing.com Nigeria

Nov 27, 2024
pulisher
Nov 27, 2024

Dai ichi Life Insurance Company Ltd Sells 1,412 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

Nov 27, 2024

United Therapeutics Corp Stock (UTHR) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$39.59
price up icon 0.51%
$18.67
price up icon 4.48%
$177.70
price up icon 0.68%
$69.84
price up icon 1.45%
$113.51
price up icon 0.38%
Cap:     |  Volume (24h):